Aixin Shi

615 total citations
23 papers, 479 citations indexed

About

Aixin Shi is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Aixin Shi has authored 23 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in Aixin Shi's work include Plant-based Medicinal Research (5 papers), Ginseng Biological Effects and Applications (4 papers) and Diabetes Treatment and Management (4 papers). Aixin Shi is often cited by papers focused on Plant-based Medicinal Research (5 papers), Ginseng Biological Effects and Applications (4 papers) and Diabetes Treatment and Management (4 papers). Aixin Shi collaborates with scholars based in China, United States and Denmark. Aixin Shi's co-authors include Bei Yan, Xin Hu, Wei Xue, Guoying Cao, Fan Dong, Kexin Li, Guanhua Du, Min Li, Guorong He and Yang Li and has published in prestigious journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology and Diabetes Obesity and Metabolism.

In The Last Decade

Aixin Shi

22 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aixin Shi China 11 220 171 74 64 62 23 479
Wenjie Zheng China 5 190 0.9× 237 1.4× 123 1.7× 70 1.1× 16 0.3× 6 490
Dake Cai China 14 274 1.2× 61 0.4× 123 1.7× 47 0.7× 27 0.4× 35 573
Lindsei K. Sarna Canada 11 202 0.9× 129 0.8× 89 1.2× 39 0.6× 74 1.2× 11 607
Wenge Huang China 14 267 1.2× 173 1.0× 137 1.9× 91 1.4× 14 0.2× 33 658
Peng An China 15 308 1.4× 113 0.7× 63 0.9× 91 1.4× 25 0.4× 33 727
Yiyi Jin China 16 353 1.6× 98 0.6× 66 0.9× 71 1.1× 16 0.3× 31 747
Mei Liu China 13 277 1.3× 310 1.8× 126 1.7× 66 1.0× 24 0.4× 32 753
Ke‐Gang Linghu China 17 300 1.4× 60 0.4× 146 2.0× 99 1.5× 38 0.6× 34 619
Fuling Luo China 12 242 1.1× 98 0.6× 89 1.2× 78 1.2× 14 0.2× 19 647
Saeed Pirouzpanah Iran 17 241 1.1× 49 0.3× 51 0.7× 112 1.8× 50 0.8× 42 691

Countries citing papers authored by Aixin Shi

Since Specialization
Citations

This map shows the geographic impact of Aixin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixin Shi more than expected).

Fields of papers citing papers by Aixin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixin Shi. The network helps show where Aixin Shi may publish in the future.

Co-authorship network of co-authors of Aixin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Aixin Shi. A scholar is included among the top collaborators of Aixin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixin Shi. Aixin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wei, Xuemei He, Liyuan Zhao, et al.. (2025). The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects. Diabetes Obesity and Metabolism. 27(5). 2777–2789. 2 indexed citations
2.
3.
Li, Yingxin, et al.. (2023). Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers. Clinical Drug Investigation. 43(6). 413–420. 2 indexed citations
4.
He, Xuemei, et al.. (2023). Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study. Diabetes Therapy. 14(8). 1387–1397. 1 indexed citations
5.
6.
Gao, Xin, Hiroyuki Oshima, Kota Kato, et al.. (2022). Pharmacokinetics and Safety of Single and Multiple Doses of Peficitinib (ASP015K) in Healthy Chinese Subjects. Drug Design Development and Therapy. Volume 16. 1365–1381. 2 indexed citations
7.
Gao, Xin, et al.. (2022). Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects. Drug Design Development and Therapy. Volume 16. 2967–2980. 7 indexed citations
8.
9.
10.
11.
Li, Min, et al.. (2017). Determination of quetiapine in human plasma by LC–MS/MS and its application in a bioequivalence study. Journal of Chromatography B. 1060. 10–14. 9 indexed citations
12.
13.
Xue, Wei, Aixin Shi, Min Li, et al.. (2016). Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers. Clinical Drug Investigation. 36(9). 713–724. 70 indexed citations
14.
Xue, Wei, Yang Liu, Yan Gao, et al.. (2016). Pharmacokinetics of ginsenoside Rg1 in rat medial prefrontal cortex, hippocampus, and lateral ventricle after subcutaneous administration. Journal of Asian Natural Products Research. 18(6). 587–595. 19 indexed citations
15.
16.
Yan, Bei, Chunmei Zhang, Xin Hu, et al.. (2016). Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS. Modern Rheumatology. 26(6). 914–922. 68 indexed citations
17.
Cao, Guoying, Bei Yan, Wei Xue, et al.. (2015). Pharmacokinetics, safety, and tolerability of single and multiple-doses of pinocembrin injection administered intravenously in healthy subjects. Journal of Ethnopharmacology. 168. 31–36. 41 indexed citations
18.
Li, Min, Aixin Shi, Wei Xue, et al.. (2014). Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. Journal of Ethnopharmacology. 156. 210–215. 141 indexed citations
19.
Yan, Bei, Guoying Cao, Xin Hu, et al.. (2014). Determination of pinocembrin in human plasma by solid‐phase extraction and LC/MS/MS: application to pharmacokinetic studies. Biomedical Chromatography. 28(12). 1601–1606. 19 indexed citations
20.
Shi, Aixin, Kexin Li, Chunhua Sun, & Guoying Cao. (2003). [Study on bioequivalence of domestic bambuterol capsules and imported tablets by high performance capillary zone electrophoresis].. PubMed. 38(12). 942–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjie Zheng Breakdown of academic impact, for papers by Dake Cai Breakdown of academic impact, for papers by Lindsei K. Sarna Breakdown of academic impact, for papers by Wenge Huang Breakdown of academic impact, for papers by Peng An Breakdown of academic impact, for papers by Yiyi Jin Breakdown of academic impact, for papers by Mei Liu Breakdown of academic impact, for papers by Ke‐Gang Linghu Breakdown of academic impact, for papers by Fuling Luo Breakdown of academic impact, for papers by Saeed Pirouzpanah
Rankless by CCL
2026